Cargando…

Metastatic medullary thyroid carcinoma: A case report

Medullary thyroid carcinoma accounts for 4% of thyroid carcinoma and originates from parafollicular cells, secreting calcitonin and carcinoembryonic antigen (CEA). Conventional radiographic modalities such as Computerized Tomography (CT), Magnetic Resonance Imaging (MRI), and Ultrasonography (U/S),...

Descripción completa

Detalles Bibliográficos
Autores principales: Niafar, Mitra, Dabiri, Shahram, Bozorgi, Farshid, Niafar, Farid, Gholami, Nasrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications Pvt Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214365/
https://www.ncbi.nlm.nih.gov/pubmed/22091276
_version_ 1782216246851272704
author Niafar, Mitra
Dabiri, Shahram
Bozorgi, Farshid
Niafar, Farid
Gholami, Nasrin
author_facet Niafar, Mitra
Dabiri, Shahram
Bozorgi, Farshid
Niafar, Farid
Gholami, Nasrin
author_sort Niafar, Mitra
collection PubMed
description Medullary thyroid carcinoma accounts for 4% of thyroid carcinoma and originates from parafollicular cells, secreting calcitonin and carcinoembryonic antigen (CEA). Conventional radiographic modalities such as Computerized Tomography (CT), Magnetic Resonance Imaging (MRI), and Ultrasonography (U/S), are used for detecting recurrences following total thyroidectomy. However, metastatic disease frequently escapes detection by the above modalities, even when its presence is suggested by persistently elevated serum calcitonin levels. In this paper, we report a case of medullary thyroid carcinoma in a 40 year-old woman who had whole body octreotide scintigraphy to evaluate and detect the origin of calcitonin and CEA secretion.
format Online
Article
Text
id pubmed-3214365
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-32143652011-11-16 Metastatic medullary thyroid carcinoma: A case report Niafar, Mitra Dabiri, Shahram Bozorgi, Farshid Niafar, Farid Gholami, Nasrin J Res Med Sci Case Report Medullary thyroid carcinoma accounts for 4% of thyroid carcinoma and originates from parafollicular cells, secreting calcitonin and carcinoembryonic antigen (CEA). Conventional radiographic modalities such as Computerized Tomography (CT), Magnetic Resonance Imaging (MRI), and Ultrasonography (U/S), are used for detecting recurrences following total thyroidectomy. However, metastatic disease frequently escapes detection by the above modalities, even when its presence is suggested by persistently elevated serum calcitonin levels. In this paper, we report a case of medullary thyroid carcinoma in a 40 year-old woman who had whole body octreotide scintigraphy to evaluate and detect the origin of calcitonin and CEA secretion. Medknow Publications Pvt Ltd 2011-04 /pmc/articles/PMC3214365/ /pubmed/22091276 Text en Copyright: © Journal of Research in Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Niafar, Mitra
Dabiri, Shahram
Bozorgi, Farshid
Niafar, Farid
Gholami, Nasrin
Metastatic medullary thyroid carcinoma: A case report
title Metastatic medullary thyroid carcinoma: A case report
title_full Metastatic medullary thyroid carcinoma: A case report
title_fullStr Metastatic medullary thyroid carcinoma: A case report
title_full_unstemmed Metastatic medullary thyroid carcinoma: A case report
title_short Metastatic medullary thyroid carcinoma: A case report
title_sort metastatic medullary thyroid carcinoma: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214365/
https://www.ncbi.nlm.nih.gov/pubmed/22091276
work_keys_str_mv AT niafarmitra metastaticmedullarythyroidcarcinomaacasereport
AT dabirishahram metastaticmedullarythyroidcarcinomaacasereport
AT bozorgifarshid metastaticmedullarythyroidcarcinomaacasereport
AT niafarfarid metastaticmedullarythyroidcarcinomaacasereport
AT gholaminasrin metastaticmedullarythyroidcarcinomaacasereport